$-0.19
(Market cap
$852 Mln
Revenue (TTM)
$214 Mln
P/E Ratio
--
P/B Ratio
4.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.1 %
-
ROCE
-- %
-
Industry P/E
44.46
-
EV/EBITDA
-14.1
-
Debt to Equity
0.2
-
Book Value
$--
-
EPS
$-0.3
-
Face value
--
-
Shares outstanding
44,349,283
10 Years Aggregate
CFO
$-264.04 Mln
EBITDA
$-317.16 Mln
Net Profit
$-374.53 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Si-Bone Inc (SIBN)
| -3.5 | 5.7 | 34.9 | 14.1 | -5.8 | -4.3 | -- |
|
BSE Sensex*
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Si-Bone Inc (SIBN)
| 40.7 | -33.0 | 54.3 | -38.8 | -25.7 | 39.1 | 2.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Si-Bone Inc (SIBN)
|
19.0 | 852.0 | 213.6 | -14.6 | -6.3 | -8.1 | -- | 4.7 |
| 62.5 | 8,018.1 | 616.9 | -75.1 | 1.7 | -9.3 | -- | 10.2 | |
| 14.5 | 9,638.1 | 6,561.1 | -578.0 | -4.5 | -10.3 | -- | 1.7 | |
| 365.1 | 9,761.6 | 2,589.3 | 222.4 | -6.0 | 3 | 44.5 | 1.3 | |
| 58.0 | 8,696.7 | 3,499.6 | -71.2 | 0.5 | -3.2 | -- | 3.8 | |
| 179.6 | 10,905.5 | 612.8 | -188.1 | -30.6 | -28.1 | -- | 16.4 | |
| 101.0 | 6,577.5 | 1,556.3 | 275.3 | 24.6 | 22.9 | 24.1 | 5.0 | |
| 90.7 | 5,403.2 | 1,579.2 | 145.6 | 14.3 | 8.9 | 37.2 | 3.2 | |
| 323.1 | 12,752.7 | 1,504.9 | 160.6 | 13.6 | 10.9 | 79.4 | 8.4 | |
| 181.0 | 9,947.9 | 785.1 | 41.5 | 9.9 | 2 | 251.8 | 4.9 |
Shareholding Pattern
View DetailsAbout Si-Bone Inc (SIBN)
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented... titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. Read more
-
CEO & Director
Ms. Laura A. Francis MBA
-
CEO & Director
Ms. Laura A. Francis MBA
-
Headquarters
Santa Clara, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Si-Bone Inc (SIBN)
What is the current share price of Si-Bone Inc (SIBN) Today?
The share price of Si-Bone Inc (SIBN) is $19.02 (NASDAQ) as of 31-Aug-2026 16:00 EDT. Si-Bone Inc (SIBN) has given a return of -5.79% in the last 3 years.
What is the current PB & PE ratio of Si-Bone Inc (SIBN)?
Since, TTM earnings of Si-Bone Inc (SIBN) is negative, P/E ratio is not available.
The P/B ratio of Si-Bone Inc (SIBN) is 4.72 times as on 28-Aug-2026, a 25 premium to its peers’ median range of 3.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-45.38 |
4.83 |
2024 |
-19.05 |
3.53 |
2023 |
-19.65 |
5.03 |
2022 |
-7.68 |
4.79 |
2021 |
-13.18 |
5.55 |
What is the 52 Week High and Low of Si-Bone Inc (SIBN)?
The 52-week high and low of Si-Bone Inc (SIBN) are Rs 21.89 and Rs 11.48 as of 01-Sep-2026.
What is the market cap of Si-Bone Inc (SIBN)?
Si-Bone Inc (SIBN) has a market capitalisation of $ 852 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Si-Bone Inc (SIBN)?
Before investing in Si-Bone Inc (SIBN), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.